ACCESS REALMONEY
Email This Article
Headlines & Perspectives
FDA Panel Tightens Anemia-Drug Standards
By
Adam Feuerstein
03/13/08 - 06:07 PM EDT
The group votes to further restrict Amgen's Aranesp and J&J's Procrit, but doesn't entirely bar their use.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
